According to Telix Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 7.15%. At the end of 2024 the company had an Operating Margin of 7.16%.
Year | Operating Margin | Change |
---|---|---|
2024 | 7.16% | 1065.16% |
2023 | 0.61% | -101% |
2022 | -61.60% | -96.25% |
2021 | -1,642.81% | 60.39% |
2020 | -1,024.25% | 14.69% |
2019 | -893.03% | -88.91% |
2018 | -8,052.54% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.